findmyKOL

Geoffrey Teehan, MD

Basic profile

Lankenau Medical Center

ORCIDNone on fileNPI
RegionWynnewood, PA · NortheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Geoffrey Teehan is a Nephrology physician affiliated with Lankenau Medical Center. OpenAlex indexes 29 publications with 386 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
29publications

Distinct works indexed by OpenAlex.

386citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
21companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

100 E Lancaster Ave Ste 130
Wynnewood, PA 190963453

Telephone

610-649-1175

Provider last certified this registry record 3 Jun 2022.

View the NPPES registry record

Industry payments

21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    49.6%
    Calcium channel blocker13.8%
    Amlodipine Besylate64%Nifedipine Er36%
    Part D53 patients
    Angiotensin receptor blocker (ARB)8.6%
    Irbesartan48%Losartan Potassium27%Valsartan25%
    Part D19 patients

    + 10 more classes in this area

  • Metabolism & gastrointestinal

    39.9%
    Vitamin D3 Analog27.9%
    Calcitriol100%
    Part D111 patients
    SGLT2 inhibitor8.4%
    Jardiance63%Farxiga37%
    Part D<11 patients

    + 2 more classes in this area

  • Musculoskeletal

    6%
    Xanthine oxidase inhibitor6%
    Allopurinol100%
    Part D21 patients
Where care is delivered (Part B)32.4% facility · 67.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”